These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2783367)

  • 1. Cerebral glucose metabolism in the course of subacute sclerosing panencephalitis.
    Huber M; Herholz K; Pawlik G; Szelies B; Jürgens R; Heiss WD
    Arch Neurol; 1989 Jan; 46(1):97-100. PubMed ID: 2783367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cerebral metabolic rate for glucose in subacute sclerosing panencephalitis.
    Yanai K; Iinuma K; Tada K; Miyabayashi S; Fukuda H; Ito M; Matsuzawa T
    Eur J Pediatr; 1987 May; 146(3):288-9. PubMed ID: 3496222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns of glucose metabolism during the course of subacute sclerosing panencephalitis as measured with 18FDG-positron-emission tomography.
    Huber M; Pawlik G; Bamborschke S; Fink GR; Karbe H; Schlenker M; Bewermeyer H; Heiss WD
    J Neurol; 1992 Mar; 239(3):157-61. PubMed ID: 1573420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose.
    Dubinsky RM; Greenberg M; Di Chiro G; Baker M; Hallett M
    Mov Disord; 1989; 4(4):310-9. PubMed ID: 2811890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional cerebral metabolic rate for glucose and cerebrospinal fluid monoamine metabolites in subacute sclerosing panencephalitis.
    Yanai K; Miyabayashi S; Iinuma K; Tada K; Fukuda H; Ito M; Matsuzawa T
    Tohoku J Exp Med; 1987 Jun; 152(2):103-9. PubMed ID: 2442847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tomographic measurement of human cerebral glucose metabolism].
    Iwasaki Y; Konishi J; Makada Y; Yonekura Y
    Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography.
    Yanai K; Iinuma K; Matsuzawa T; Ito M; Miyabayashi S; Narisawa K; Ido T; Yamada K; Tada K
    Eur J Nucl Med; 1987; 13(6):292-6. PubMed ID: 3499326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional cerebral glucose metabolism in anorexia nervosa measured by positron emission tomography.
    Herholz K; Krieg JC; Emrich HM; Pawlik G; Beil C; Pirke KM; Pahl JJ; Wagner R; Wienhard K; Ploog D
    Biol Psychiatry; 1987 Jan; 22(1):43-51. PubMed ID: 3491631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET in a 10-year-old female patient with subacute sclerosing panencephalitis.
    Dimitrakopoulou-Strauss A; Wilmsmeyer M; König S; Schubert S; Neff KW; Haberkorn U; Strauss LG
    Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1100-1. PubMed ID: 16733688
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomography demonstrated localized luxury perfusion in subacute sclerosing panencephalitis.
    Yoshikawa H; Fueki N; Yoneyama H; Ogawa M; Sakuragawa N
    J Child Neurol; 1990 Oct; 5(4):311-5. PubMed ID: 2246484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A correlative study of FDG PET, MRI/CT, electroencephalography, and clinical features in subacute sclerosing panencephalitis.
    Yilmaz K; Yilmaz M; Mete A; Celen Z
    Clin Nucl Med; 2010 Sep; 35(9):675-81. PubMed ID: 20706040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Marinesco-Sjögren syndrome examined by computed tomography, magnetic resonance, and 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography.
    Bromberg MB; Junck L; Gebarski SS; McLean MJ; Gilman S
    Arch Neurol; 1990 Nov; 47(11):1239-42. PubMed ID: 2241622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.
    Hommer D; Andreasen P; Rio D; Williams W; Ruttimann U; Momenan R; Zametkin A; Rawlings R; Linnoila M
    J Neurosci; 1997 Apr; 17(8):2796-806. PubMed ID: 9092601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Wienhard K
    Brain Res; 1985 Feb; 327(1-2):362-6. PubMed ID: 3872693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subacute sclerosing panencephalitis. Imaging and clinical correlation.
    Bohlega S; al-Kawi MZ
    J Neuroimaging; 1994 Apr; 4(2):71-6. PubMed ID: 8186532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metabolism of glucose in benign hereditary chorea.
    Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
    Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral glucose metabolism compared in rodents and humans.
    Blin J; Ray CA; Chase TN; Piercey MF
    Brain Res; 1991 Dec; 568(1-2):215-22. PubMed ID: 1814569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.
    Sasaki M; Ichiya Y; Hosokawa S; Otsuka M; Kuwabara Y; Fukumura T; Kato M; Goto I; Masuda K
    Ann Nucl Med; 1992 Nov; 6(4):241-6. PubMed ID: 1489634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
    Hanakawa T; Fukuyama H; Akiguchi I; Kato M; Kimura J; Shibasaki H
    Rinsho Shinkeigaku; 1996 May; 36(5):655-60. PubMed ID: 8905984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.